肺癌
药品
医学
肿瘤科
内科学
重症监护医学
药理学
作者
Khurram Haq Nawaz,Rachel M. Webster
摘要
The year 2015 saw the approval of six new targeted therapies for the treatment of non-small-cell lung cancer (NSCLC). This analysis discusses recently approved as well as late-stage compounds and examines how different drug classes will affect the NSCLC market.
科研通智能强力驱动
Strongly Powered by AbleSci AI
pluto
cdercder
昏睡的蟠桃
bc
归尘
Rye227
冰魂
jenningseastera
乐乐
ss
巴拉巴拉巴拉拉
平常的毛豆
zmnzmnzmn
iNk
HEIKU
科研小民工
不倦
遇上就这样吧
back you up
顺心香菇
皖公网安备34019202002308
